NCT04239898

Brief Summary

Microgreens are an emerging horticultural food crop with potential to improve human health. Previous research suggests they have broad consumer acceptance and that the micronutrient and bioactive compound levels are higher than that of their mature counterparts. To date, no studies have explored the feasibility of microgreen consumption, gastrointestinal tolerance of microgreen consumption, or their potential health impacts in humans. Therefore, the overall goal of this study is to explore the feasibility and acceptability of daily microgreen consumption, gastrointestinal tolerability, and potential health impacts of red cabbage and red beet microgreens in healthy middle-aged/older men and postmenopausal women - a population inherently at risk for chronic disease, e.g. cardiovascular disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 16, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2019

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2019

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

November 12, 2019

Last Update Submit

September 10, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants retained

    The number of participants retained versus lost to follow-up throughout the entire study

    Baseline to 6 weeks

  • Adherence to the intervention

    Adherence will be determined for each 2-week microgreen intervention through a daily microgreen consumption log

    Baseline to 2 weeks

Secondary Outcomes (6)

  • Gastrointestinal symptom self-assessment

    Baseline to 2 weeks

  • Gastrointestinal health

    Baseline to 2 weeks

  • Blood pressure

    Baseline to 2 weeks

  • Augmentation index

    Baseline to 2 weeks

  • Microbiota modulation

    Baseline to 2 weeks

  • +1 more secondary outcomes

Other Outcomes (1)

  • Changes in plasma metabolites

    Baseline to 2 weeks

Study Arms (2)

Red cabbage microgreens

EXPERIMENTAL

2 cups of fresh red cabbage microgreens per day

Other: Red cabbage microgreens

Red beet microgreens

EXPERIMENTAL

2 cups of fresh red beet microgreens per day

Other: Red beet microgreens

Interventions

2 cups per day

Red cabbage microgreens

2 cups per day

Red beet microgreens

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or postmenopausal
  • Aged 45-70

You may not qualify if:

  • Cardiovascular disease, hypertension, diabetes, neuropathy, thrombosis, cancer, gastrointestinal, kidney, liver, lung, or pancreatic disease
  • Taking medication for high cholesterol, triglycerides, or blood sugar, or are taking testosterone medications
  • Blood pressure ≥ 130/80 mm Hg, triglyceride levels \> 200 mg/dL, low-density lipoprotein cholesterol levels ≥ 160 mg/dL, total cholesterol levels ≥ 240 mg/dL, and/or hemoglobin A1c ≥ 6.5%
  • Weight change ≥ 3 kg (6.6 lb.) in the past 3 months prior to starting the study, are actively trying to lose weight, or are unwilling to remain weight stable throughout the study
  • Have a BMI less than 18.5 or greater than 30 kg/m2
  • Are not willing to maintain normal eating/drinking and exercise habits over the duration of the study
  • Currently smoke cigarettes or have a history of smoking cigarettes in the past 12 months
  • Taking antibiotics or have taken them within one month of starting the study
  • Binge and/or heavy drinker (\>4 drinks on any given occasion and/or \>14 drinks/week for men)
  • Have allergies or contraindication to study foods, procedures, or procedure supplies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Food Science and Human Nutrition, Colorado State University

Fort Collins, Colorado, 80523-1571, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2019

First Posted

January 27, 2020

Study Start

July 16, 2019

Primary Completion

November 22, 2019

Study Completion

November 30, 2019

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations